New Chair brings extensive financial and life sciences experience with industry-leading companies SOUTH SAN FRANCISCO, Calif., March 17, 2022 /PRNewswire/ -- Mission Bio, Inc., the pioneer in ...
Pivot Bio, whose microbial nitrogen products have become increasingly popular, has announced that Chris Abbott will become its new Chief Executive Officer, replacing co-founder and now-former CEO ...
OXFORD, United Kingdom, May 01, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc (BRNS), a clinical-stage biopharmaceutical company developing novel T cell ...
DALLAS, June 11, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced the ...
DALLAS, Aug. 27, 2025 /PRNewswire/ -- Women In Bio, the premier organization dedicated to advancing women in the life sciences, today announces Gina Ford as its first-ever Chief Executive Officer, ...
MALVERN, Pa., May 25, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement ...
—Senior healthcare executive with three decades' global experience across large pharma and diverse start-up organizations in finance and business development— WEST HILLS, Calif., Aug. 9, 2022 ...
With its injectable biosensor technology well into the clinical development stage, Glympse Bio has its sights set on revolutionizing the way we diagnose diseases and track their progression throughout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results